Pascal Soriot, CEO of AstraZeneca, said on Monday that he sees the pharma company's breast cancer blood test, which tracks signs of returning cancer, as "the future of cancer treatment."
--
Support podtube.me continuity as a free service. Become a Patreon or make an one-time donation
--
Video at Youtube: https://www.youtube.com/watch?v=7HJo8ZX2bj4